fda ban on compounded semaglutide is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified what states have banned semaglutide
Description
Independent editorial review of Noom
How do GLP-1 medicines improve liver health through #weightloss independent mechanisms

Phase 2 insights on this receptor agonist's weight loss efficacy versus semaglutide and tirzepatide.

Endocrinologist Dr Arti Thangudu shares why this moment matters for access, equity, and the future of metabolic care

Many people taking Ozempic and related drugs have reported mental health concerns

How do we keep members engaged long enough to see results
